Overview of adverse reactions to nefopam: An analysis of the French Pharmacovigilance database

Fundamental and Clinical Pharmacology

Volumn 21, Issue 5, 2007, Pages 555-558

  Durrieu, G ^a,b   Olivier, P ^a,b   Bagheri, H ^a,b   Montastruc, J L ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Adverse drug reactions; Nefopam; Pharmacovigilance

Indexed keywords

AMOXICILLIN; KETAMINE; KETOPROFEN; NEFOPAM; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTICLE; CONFUSION; CONVULSION; DELIRIUM; DISEASE SEVERITY; DIZZINESS; DRUG EXPOSURE; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ERYTHEMA; FEMALE; FRANCE; HALLUCINATION; HEART FAILURE; HUMAN; HYPOTENSION; IRRITABILITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MYDRIASIS; NAUSEA; NERVOUSNESS; OUTCOME ASSESSMENT; PATIENT INFORMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SWEATING; SYNCOPE; TACHYCARDIA; URINE RETENTION; URTICARIA; VERTIGO; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; ANAPHYLAXIS; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEFOPAM; PHARMACOEPIDEMIOLOGY; SEIZURES;

EID: 34548658623     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00499.x     Document Type: Article

References (11)

1. Fuller R.W., Snoddy H.D. Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice. Neuropharmacology (1993) 32 995 999.
2. Novelli A., Diaz-Trelles R., Gropetti A., Fernandez-Sanchez M.T. Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels. Amino Acids (2005) 25 183 191.
3. Heel R.C., Brogden R.N., Pakes G.E., Speight T.M., Avery G.S. Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 19 249 267.
4. Pillans P.I., Woods D.J. Adverse reactions associated to nefopam. N. Z. Med. J. (1995) 108 832 834.
5. Edwards I., Aronson J. Adverse drug reactions: definitions, diagnosis, and management. Lancet (2000) 356 1255 1260.
6. Arrêté du 28 Avril 2005 relatif aux bonnes pratiques de pharmacovigilance. French Official Journal (2005) 9087 9102.
7. Bégaud B., Evreux J.C., Jouglard J., Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Thérapie (1985) 40 111 118.
8. Godier A., Babinet A., El Metaoua S., Fulgencio J.P., Bonnet F. Postoperative confusion revealing acute nefopam intoxication. Ann. Fr. Anesth. Reanim. (2002) 21 538 539.
9. Urwin S.C., Smith H.S. Fatal nefopam overdose. Br. J. Anesth. (1999) 83 501 502.
10. Piercy D.M., Cumming J.A., Dawling S., Henry J.A. Death due to overdose of nefopam. Br. Med. J. (1981) 283 1508 1509.
11. ®). J. Anal. Toxicol. (2002) 26 239 243.